Results 131 to 140 of about 97,795 (300)

Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long‐Term Survival Outcomes

International Journal of Cancer, EarlyView.
ABSTRACT Long‐term survival data for patients with locally advanced gastro‐esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long‐term disease‐free survival (DFS) and overall survival (OS) outcomes of such patients treated with a novel neoadjuvant chemoimmunotherapy regimen, aDCF (avelumab with ...
Thierry Alcindor, James Tankel, Pierre‐Olivier Fiset, Mehrnoush Dehghani, Nicholas Bertos, Carmen Mueller, Jonathan Cools‐Lartigue, Sophie Camilleri‐Broet, Lorenzo Ferri   +8 more
wiley   +1 more source

Surgery versus chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer: a retrospective cohort study

Scientific Reports
To compare survival outcomes between surgery and chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer. Stage T1bN0M0 esophageal cancer patients treated with either surgery or chemoradiotherapy were extracted from the Surveillance ...
Zu-Yi Chen, Shou-Feng Wang, Huan-Wei Liang, Yang Liu, Wei Huang, Xin-Bin Pan   +5 more
doaj   +1 more source

Real‐World Experience With Multimodal Treatment of Resectable Stage II–III Non‐Small Cell Lung Cancer: A Single Institutional Analysis

International Journal of Cancer, EarlyView.
ABSTRACT Neoadjuvant therapy has recently become an integral component of multimodal treatment for resectable lung cancer. However, real‐world data on perioperative morbidity and treatment adherence remain limited. This study aimed to assess the feasibility and safety of different neoadjuvant treatment approaches applied within daily clinical routine ...
Raffaella Griffo, Benedikt Niedermaier, Laura V. Klotz, Marc Schneider, Michael Allgäuer, Marc Kriegsmann, Romina M. Roesch, Lena Brendel, Henrike Deissner, Farastuk Bozorgmehr, Petros Christopoulos, Michael Thomas, Hauke Winter, Martin E. Eichhorn, Florian Eichhorn   +14 more
wiley   +1 more source

Chemoradiotherapy for inoperable lung cancer patients using singlet oxygen therapy

, 2001
Singlet oxygen therapy (SOT) based оn the principle of photoactivation of atmospheric air was used during combined chemoradiotherapy for inoperable lung cancer patients.
Орел, В. Е., Смоланка, І. І.   +1 more
core  

Clinical Outcomes of Gemcitabine Plus Nab‐Paclitaxel‐Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT‐05): A Prospective, Single‐Arm, Phase II Study

International Journal of Cancer, EarlyView.
ABSTRACT Although chemoradiotherapy (CRT) has exhibited activity against locally advanced pancreatic cancer (LAPC), no standard regimen has been established. We previously completed a Phase I trial of CRT with gemcitabine plus nab‐paclitaxel (GnP) and established the recommended dose.
Hironori Yamada, Haruyoshi Tanaka, Suguru Yamada, Hideki Takami, Masamichi Hayashi, Nobuhiko Nakagawa, Keisuke Kurimoto, Yoshikuni Inokawa, Nobuyuki Watanabe, Takuya Ishikawa, Masayuki Okumura, Hiroshi Ogawa, Masahiko Ando, Osamu Maeda, Junpei Yamaguchi, Shinji Naganawa, Hiroki Kawashima, Tsutomu Fujii, Yukihiro Yokoyama, Tomoki Ebata, Mitsuro Kanda   +20 more
wiley   +1 more source

The Use of Combination Palliative Radiotherapy and Single‐Agent Immunotherapy for the Management of Head and Neck Squamous Cell Carcinoma (HNSCC) in the United Kingdom (UK)

International Journal of Cancer, EarlyView.
ABSTRACT Clinical data on combined Immunotherapy (IO) and palliative radiotherapy (RT) in HNSCC is scarce. HNSCC Palliative RT differs from curative intent RT as it does not involve elective nodal irradiation; therefore, an immune response may be more likely.
Chris Hurt, Sarah Park, Jonathan Chambers, Caroline Brammer, Matthew Griffin, Vishnu Harilal, Ruth Stone, Puteri Abdul Haris, Rebecca Shakir, Louise Karsera, Will Ince, Femi Adeoye, Daljit Gahir, James Lester, Ehiosa Charles Okuofo, Saira Khalique, Mayumi Forster, Philippa Smith, Oliver Donnelly, Lyndon Ridges‐Jones, James Hesford, Naomi Cole   +21 more
wiley   +1 more source

Lymphovascular space involvement as a prognostic factor for survival outcomes in vulvar cancer: A systematic review and meta‐analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Lymphovascular space involvement (LVSI) is a significant prognostic factor of survival outcomes in gynecologic oncology. Synthetic studies on vulvar cancer are lacking as well as clear consensus about the importance of LSVI in vulvar cancer.
Vasilios Pergialiotis, Maria Fanaki, Michail Panagiotopoulos, Vasilios Lygizos, Dimitrios Efthimios Vlachos, Nikolaos Thomakos, Dimitrios Haidopoulos   +6 more
wiley   +1 more source

A Multimodal Deep Learning Framework Integrating Tumor Microenvironment Niches for Overall Survival Prediction in Esophageal Squamous Cell Carcinoma

iMetaMed, EarlyView.
The training cohort (n = 273) and internal validation cohort (n = 63) were obtained from Qilu Hospital of Shandong University, while the external validation cohort (n = 114) was derived from Liaoning Cancer Hospital. Multimodal input data included CT images with corresponding tumor segmentation masks, whole‐slide pathology images (WSIs), clinical data,
Yuanyue Zhang, Xiaoyan Li, Henan Zhang, Guang Yang, Chulong Zhang, Xiaomin Ni, Xuefei Lin, Huahui Li, Yan Min, Wei Teng, Yaoqin Xie, Hui Yang, Yang Zhang, Xin Hong, Md Tauhidul Islam, Shunsuke Koga, Zhihao Xie, Ping Zhou, Jingdong Zhang, Hao Yu, Xiaokun Liang, Jianbo Wang   +21 more
wiley   +1 more source

Pseudoprogression of malignant glioma in Chinese patients receiving concomitant chemoradiotherapy

, 2012
Objectives To investigate the frequency of pseudoprogression of glioblastoma in Chinese patients receiving concomitant chemoradiotherapy and investigate its association with pseudoprogression and tumour molecular marker O6- methylguanine-DNA ...
Tang, Peggy, Chan, Danny T.M., Lau, Claire K.Y., Zhu, X. L., Ma, Brigette B.Y., Ng, Stephanie C.P., Kam, Michael K.M., Ng, Rebecca Y.T., Wong, George K.C., Poon, W. S., Ng, H. K., Siu, Deyond Y.W., Pang, Jesse C.S.   +12 more
core  

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source